rs12040949 - RPRD2

Magnitude 2.2 · 2 studies on file

Reported associations

  • Identification of new therapeutic targets for osteoarthritis through genome-wide analyses of UK Biobank - Unknown journal (n.d.) · Unknown authors · PubMed 30664745

    ABSTRACT: Osteoarthritis is the most common musculoskeletal disease and the leading cause of disability globally. Here, we perform a genome-wide association study for osteoarthritis (77,052 cases and 378,169 controls), analysing 4 phenotypes: knee osteoarthritis, hip osteoarthritis, knee and/or hip osteoarthritis, and any osteoarthritis. We discover 64 signals, 52 of them novel, more than doubling the number of established disease loci. Six signals fine map to a single variant. We identify putative effector genes by integrating eQTL colocalization, fine-mapping, human rare disease, animal model, and osteoarthritis tissue expression data. We find enrichment for genes underlying monogenic forms of bone development diseases, and for the collagen formation and extracellular matrix organisation

  • Translational genomics of osteoarthritis in 1,962,069 individuals - Unknown journal (n.d.) · Unknown authors · PubMed 40205036

    ABSTRACT: Osteoarthritis is the third most rapidly growing health condition associated with disability, after dementia and diabetes. By 2050, the total number of patients with osteoarthritis is estimated to reach 1 billion worldwide. As no disease-modifying treatments exist for osteoarthritis, a better understanding of disease aetiopathology is urgently needed. Here we perform a genome-wide association study meta-analyses across up to 489,975 cases and 1,472,094 controls, establishing 962 independent associations, 513 of which have not been previously reported. Using single-cell multiomics data, we identify signal enrichment in embryonic skeletal development pathways. We integrate orthogonal lines of evidence, including transcriptome, proteome and epigenome profiles of primary joint tiss


Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.

Lifestyle context

Concrete actions anchored to the cited research. We do not prescribe, we describe.

Discuss with your doctor

  • Osteoarthritis risk assessment and prevention strategies High

    Genetic predisposition to hip osteoarthritis warrants proactive risk management planning with a clinician.

    Discuss screening protocols, preventive measures, and monitoring with primary care or rheumatology

Exercise

  • Low-impact weight-bearing exercise Moderate

    Joint-protective exercise strengthens musculature and maintains cartilage health in those with OA genetic predisposition.

    150 minutes/week moderate-intensity low-impact activity (walking, swimming, cycling, elliptical)

Lifestyle

  • Maintain healthy body weight Moderate

    Obesity amplifies osteoarthritis risk; weight management is a primary modifiable factor in genetic predisposition.

    Target BMI 18.5-24.9 through balanced nutrition and caloric balance

Screening

  • Hip osteoarthritis imaging and clinical monitoring High

    Genetic variants at this locus are strongly associated with increased hip osteoarthritis risk across large populations.

    Baseline imaging (X-ray or MRI) recommended; clinical assessment for joint pain/function yearly